FDA — authorised 7 February 1979
- Application: NDA017862
- Marketing authorisation holder: HIKMA
- Local brand name: REGLAN
- Indication: INJECTABLE — INJECTION
- Status: approved
FDA authorised Metclopramide on 7 February 1979
Yes. FDA authorised it on 7 February 1979; FDA authorised it on 30 December 1980.
HIKMA holds the US marketing authorisation.